Acute kidney injury: Diagnosis and treatment with peritoneal dialysis, hemodialysis, and CRRT

Pediatric Dialysis, Second Edition

Volumn , Issue , 2012, Pages 697-736

  Brophy, Patrick D ^a   Yap, Hui Kim ^b   Alexander, Steven R ^c  

^a UNIVERSITY OF IOWA   (United States)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

Author keywords

Acute kidney injury; AKI; CRRT; Hemodialysis; Peritoneal dialysis

Indexed keywords

EID: 84928195292     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-0721-8_37     Document Type: Chapter

References (208)

1. Lameire N, Van Biesen W, Vanholder R. Acute kidney injury. Lancet. 2005;365(9457):417-30.
2. Bellomo R, Kellum J, Ronco C. Acute kidney injury: time for consensus. Intensive Care Med. 2001;27(11): 1685-8.
3. Singri N, Ahya SN, Levin ML. Acute kidney injury. JAMA. 2003;289(6):747-51.
4. Uchino S, et al. Acute kidney injury in critically ill patients: a multinational, multicenter study. JAMA. 2005;294(7):813-8.
5. Flynn JT, et al. Peritoneal dialysis for management of pediatric acute kidney injury. Perit Dial Int. 2001;21(4):390-4.
6. Bellomo R, et al. Acute kidney injury - definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the Acute Dialysis Quality Initiative (ADQI) group. Crit Care. 2004; 8(4):R204-12.
7. Bell M, et al. Optimal follow-up time after continuous renal replacement therapy in actual renal failure patients stratified with the RIFLE criteria. Nephrol Dial Transplant. 2005;20(2):354-60.
8. Abosaif NY, et al. The outcome of acute kidney injury in the intensive care unit according to RIFLE: model application, sensitivity, and predictability. Am J Kidney Dis. 2005;46(6):1038-48.
9. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A, Acute Kidney Injury Network. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.
10. Akcan-Arikan A, Zappitelli M, Loftis LL, Washburn KK, Jefferson LS, Goldstein SL. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int. 2007;71:1028-35.
11. Zappitelli M, Bernier PL, Saczkowski RS, Tchervenkov CI, Gottesman R, Dancea A, Hyder A, Alkandari O. A small post-operative rise in serum creatinine predicts acute kidney injury in children undergoing cardiac surgery. Kidney Int. 2009;76:885-92.
12. Palmieri T, Lavrentieva A, Greenhaigh D. An assessment of acute kidney injury with modified RIFLE criteria in pediatric patients with severe burns. Intensive Care Med. 2009;35:2125-9.
13. Bakkaloglu A, Kalyoncu M, Poyrazoglu H, Delibas A, Ozkaya O, Peru H, Alpay H, Soylemezoglu O, Gur-Given A, Bak M, Bircan Z, Akil I, Ozcakar B, Uncu N, Karabay-Bayazit A, Sonmez F, Turkish Society for Pediatric Nephrology Acute Kidney Injury Study Group. Etiology and outcome of acute kidney injury in children. Pediatr Nephrol. 2010;25:1453-61.
14. Plotz FB, Bouma AB, van Wijk JA, Kneyber MC, Bokenkamp A. Pediatric acute kidney injury in the ICU: an independent evaluation of pRIFLE criteria. Intensive Care Med. 2008;34:1713-7.
15. Zappitelli M, Moffet BS, Hyder A, Goldstein SL. Acute kidney injury in non-critically ill children treated with aminoglycoside antibiotics in a tertiary healthcare center: a retrospective cohort study. Nephrol Dial Transplant. 2011;26:144-50.
16. Picca S, et al. Risks of acute kidney injury after cardiopulmonary bypass surgery in children: a retrospective 10-year case-control study. Nephrol Dial Transplant. 1995;10(5):630-6.
17. Moghal NE, Brocklebank JT, Meadow SR. A review of acute kidney injury in children: incidence, etiology and outcome. Clin Nephrol. 1998;49(2):91-5.
18. Leteurtre S, et al. Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study. Lancet. 2003; 362(9379): 192-7.
19. Bonventre JV, Weinberg JM. Recent advances in the pathophysiology of ischemic acute kidney injury. J Am Soc Nephrol. 2003;14(8):2199-210.
20. Sutton TA, Fisher CJ, Molitoris BA. Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int. 2002;62:1532-9.
21. Brady HR, Clarkson MR, Lieberthal W. Acute kidney injury. In: Brenner BM, editor. Brenner & Rector’s The Kidney. 7th ed. Philadelphia: Saunders; 2004. p. 1215-70.
22. Andreoli SP. Clinical evaluation and management. In: Avner ED, Harmon WE, Niaudet P, editors. Pediatric nephrology. 5th ed. Baltimore: Lippincott Williams and Wilkins; 2004. p. 1233-34.
23. Arora P, et al. Prognosis of acute kidney injury in children: a multivariate analysis. Pediatr Nephrol. 1997; 11 (2): 153-5.
24. Flynn JT. Causes, management approaches, and outcome of acute kidney injury in children. Curr Opin Pediatr. 1998;10(2):184-9.
25. Bunchman TE, et al. Pediatric acute kidney injury: outcome by modality and disease. Pediatr Nephrol. 2001; 16(12): 1067-71.
26. Hui-Stickle S, Brewer ED, Goldstein SL. Pediatric AKI epidemiology at a tertiary care center from 1999 to 2001. Am J Kidney Dis. 2005;45(1): 96-101.
27. Olowu WA, Adelusola KA. Pediatric acute kidney injury in southwestern Nigeria. Kidney Int. 2004;66(4):1541-8.
28. Anochie IC, Eke FU. Acute kidney injury in Nigerian children: Port Harcourt experience. Pediatr Nephrol. 2005;20(11):1610-4.
29. Mabina MH, Moodley J, Pitsoe SB. The use of traditional herbal medication during pregnancy. Trop Doct. 1997;27(2):84-6.
30. Kadiri S, et al. The causes and course of acute tubular necrosis in Nigerians. Afr J Med Med Sci. 1992;21(1):91-6.
31. Jha V, Chugh KS. Nephropathy associated with animal, plant, and chemical toxins in the tropics. Semin Nephrol. 2003;23(1):49-65.
32. Liano F, et al. The spectrum of acute kidney injury in the intensive care unit compared with that seen in other settings. The Madrid Acute kidney injury Study Group. Kidney Int Suppl. 1998;66:S16-24.
33. Uchino S, et al. Diuretics and mortality in acute kidney injury. Crit Care Med. 2004;32(8):1669-77.
34. Brivet FG, et al. Acute kidney injury in intensive care units - causes, outcome, and prognostic factors of hospital mortality; a prospective, multicenter study. French Study Group on acute kidney injury. Crit Care Med. 1996;24(2):192-8.
35. Cosentino F, Chaff C, Piedmonte M. Risk factors influencing survival in ICU acute kidney injury. Nephrol Dial Transplant. 1994;9(Suppl 4):179-82.
36. Medina Villanueva A, et al. Acute kidney injury in critically-ill children. A preliminary study. An Pediatr (Barc). 2004;61(6):509-14.
37. Skippen PW, Krahn GE. Acute kidney injury in children undergoing cardiopulmonary bypass. Crit Care Resusc. 2005;7(4):286-91.
38. Taber SS. Drug-associated renal dysfunction. Crit Care Clin. 2006;22(2):357-74.
39. Tune BM, Reznik VM, Mendoza SA. Renal complications of drug therapy. In: Holliday MA, Barratt TM, Avner ED, editors. Pediatric nephrology. 3rd ed. Baltimore, MD: Williams and Wilkins; 1994. p. 1212-26.
40. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39(5):930-6.
41. Rihal CS, et al. Incidence and prognostic importance of acute kidney injury after percutaneous coronary intervention. Circulation. 2002;105(19):2259-64.
42. Barrett BJ, Carlisle EJ. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodi- nated contrast media. Radiology. 1993; 188(1): 171-8.
43. Solomon R. The role of osmolality in the incidence of contrast-induced nephropathy: a systematic review of angiographic contrast media in high risk patients. Kidney Int. 2005;68(5):2256-63.
44. Pannu N, Wiebe N, Tonelli M. Prophylaxis strategies for contrast-induced nephropathy. JAMA. 2006; 295(23):2765-79.
45. Cantley LG, et al. Role of endothelin and prostaglandins in radiocontrast-induced renal artery constriction. Kidney Int. 1993;44(6):1217-23.
46. Pflueger A, et al. Role of adenosine in contrast media-induced acute kidney injury in diabetes mellitus. Mayo Clin Proc. 2000;75(12):1275-83.
47. Persson PG. The cancer foundation: donations greater than ever. Lakartidningen. 2006; 103 (6): 391.
48. Rudnick MR, et al. Nephrotoxic risks of renal angiography: contrast media-associated nephrotoxicity and atheroembolism - a critical review. Am J Kidney Dis. 1994;24(4):713-27.
49. Peixoto AJ. Critical issues in nephrology. Clin Chest Med. 2003;24(4):561-581.
50. Mato AR, et al. A predictive model for the detection of tumor lysis syndrome during AML induction therapy. Leuk Lymphoma. 2006;47(5):877-83.
51. Sallan S. Management of acute tumor lysis syndrome. Semin Oncol. 2001;28(2 Suppl 5):9-12.
52. Wang LY, et al. Recombinant urate oxidase (rasbu- ricase) for the prevention and treatment of tumor lysis syndrome in patients with hematologic malignancies. Acta Haematol. 2006;115(1-2):35-8.
53. Goldman SC, et al. A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. Blood. 2001;97(10):2998-3003.
54. Davidson MB, et al. Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome. Am J Med. 2004;116(8):546-54.
55. Palevsky PM. Acute kidney injury. J Am Soc Nephrol. 2003;2(2):41-76.
56. Rose BD. Meaning and application of urine chemistries. Clinical physiology of acid-base and electrolyte disorders. 5th edition. 2001. p. 405-14.
57. Zarich S, Fang LS, Diamond JR. Diamond, fractional excretion of sodium. Exceptions to its diagnostic value. Arch Intern Med. 1985;145(1):108-12.
58. Miller TR, et al. Urinary diagnostic indices in acute kidney injury: a prospective study. Ann Intern Med. 1978;89(1):47-50.
59. Goldstein MH, Lenz PR, Levitt MF. Effect of urine flow rate on urea reabsorption in man: urea as a “tubular marker”. J Appl Physiol. 1969;26(5): 594-9.
60. Carvounis CP, Nisar S, Guro-Razuman S. Significance of the fractional excretion of urea in the differential diagnosis of acute kidney injury. Kidney Int. 2002;62(6):2223-9.
61. Zhou H, et al. Acute kidney injury biomarkers-need, present status, and future promise. J Am Soc Nephrol (NephSAP). 2006;5(2):63-71.
62. Herget-Rosenthal S, et al. Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. Clin Chem. 2004;50(3):552-8.
63. Herget-Rosenthal S, et al. Early detection of acute kidney injury by serum cystatin C. Kidney Int. 2004;66(3): 1115-22.
64. Villa P, et al. Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients. Crit Care. 2005;9(2):R139-43.
65. White C, et al. Estimating glomerular filtration rate in kidney transplantation: a comparison between serum creatinine and cystatin C-based methods. J Am Soc Nephrol. 2005;16(12):3763-70.
66. Burchard GD, et al. Renal dysfunction in children with uncomplicated, Plasmodium falciparum malaria in Tamale, Ghana. Ann Trop Med Parasitol. 2003;97(4):345-50.
67. Han WK, et al. Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 2002;62(1):237-44.
68. Kjeldsen L, Cowland JB, Borregaard N. Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse. Biochim Biophys Acta. 2000;1482(1-2):272-83.
69. Mishra J, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365(9466): 1231-8.
70. Trachtman H, et al. Urinary neutrophil gelatinase- associated lipocalcin in D + HUS: a novel marker of renal injury. Pediatr Nephrol. 2006;21(7):989-94.
71. Melnikov VY, et al. Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute kidney injury. J Clin Invest. 2001;107(9):1145-52.
72. Parikh CR, et al. Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis. 2004;43(3):405-14.
73. Parikh CR, et al. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol. 2005;16(10):3046-52.
74. Parikh CR, et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int. 2006;70(1):199-203.
75. du Cheyron D, et al. Urinary measurement of Na+/H + exchanger isoform 3 (NHE3) protein as new marker of tubule injury in critically ill patients with AKI. Am J Kidney Dis. 2003;42(3):497-506.
76. Kiely EA, Hartnell GG, Gibson RN, et al. Measurement of bladder volume by real-time ultrasound. Br J Urol. 1987;60:33-35.
77. Ireton RC, Krieger JN, Cardenas DD, et al. Bladder volume determination using a dedicated, portable ultrasound scanner. J Urol. 1990;143:909-11.
78. Mainprize TC, Drutz HP. Accuracy of total bladder volume and residual urine measurements: comparison between real-time ultrasound and catheterization. Am J Obstet Gynecol. 1989;160:1013-16.
79. Coleman BG. Ultrasonography of the upper genitourinary tract. Urol Clin North Am. 1985;12:633-44.
80. Mercado-Deane MG, Beeson JE, John SD. US of renal insufficiency in neonates. Radiographies. 2002; 22(6): 1429-38.
81. Krumme B, Blum U, Schwertfeger E, et al. Diagnosis of renovascular disease by intra- and extra-renal Doppler scanning. Kidney Int. 1996;50:1288-92.
82. Platt JF, Rubin JM, Ellis JH. Lupus nephritis: predictive value of conventional and Doppler US and comparison with serologic and biopsy parameters. Radiology. 1997;203:82-8.
83. Goldfarb CR, Srivastava NC, Grotas AB, Ongseng F, Nagler HM. Radionuclide imaging in urology. Urol Clin North Am. 2006;33(3):319-28.
84. Sherman RA, Byun KJ. Nuclear medicine in acute and chronic renal failure. Semin Nucl Med. 1982; 12:265-79.
85. Buckley JC, McAninch JW. The diagnosis, management, and outcomes of pediatric renal injuries. Urol Clin North Am. 2006;33:33-40.
86. Alsikafi NF, Rosenstein DI. Staging, evaluation, and nonoperative management of renal injuries. Urol Clin North Am. 2006;33:13-9.
87. Kawashima A, Glockner JF, King BF. CT urography and MR urography. Radiol Clin North Am. 2003;41 (5):945-61.
88. Huang AJ, Lee VS, Rusinek H. MR imaging of renal function. Radiol Clin North Am. 2003;41(5): 1001-1017.
89. Nolte-Ernsting CCA, Adam GB, Gunther RW. MR urography: examination techniques and clinical applications. Eur Radiol. 2001;11:355-72.
90. Borthne AS, Pierre-Jerome C, Gjesdal KI, Storaas T, Courivaud F, Eriksen M. Pediatric excretory MR urography: comparative study of enhanced and non-enhanced techniques. Eur Radiol. 2003;13(6): 1423-27.
91. Prince MR, Zhang HL, Peowda JC, Grossman ME, Silvers DN. Nephrogenic systemic fibrosis and its impact on abdominal imaging. Radiographics. 2009;29:1565-74.
92. Al Makdama A, Al-Akash S. Safety of percutaneous renal biopsy as an outpatient procedure in pediatric patients. Ann Saudi Med. 2006;26(4):303-5.
93. Vande Walle J, Mauel R, Raes A, Vandekerckhove K, Donckerwolcke R. AKI in children with minimal change nephrotic syndrome may be related to functional changes of the glomerular basal membrane. Am J Kidney Dis. 2004;43(3):399-404.
94. Subtirelu MM, Flynn JT, Schechner RS, Pullman JM, Feuerstein D, Del Rio M. Acute kidney injury in a pediatric kidney allograft recipient treated with intravenous immunoglobulin for parvovirus B19 induced pure red cell aplasia. Pediatr Transplant. 2005;9(6):801-4.
95. Demirkaya E, Atay AA, Musabak U, Sengul A, Gok F. Ceftriaxone-related hemolysis and acute kidney injury. Pediatr Nephrol. 2006;5:733-6.
96. Korbet SM. Percutaneous renal biopsy. Semin Nephrol. 2002;22:254-67.
97. Solez K, Racusen LC. Role of the renal biopsy in acute kidney injury. Contrib Nephrol. 2001;132: 68-75.
98. Preston RA, Stemmer CL, Materson BJ, et al. Renal biopsy in patients 65 years of age or older: an analysis of the results of 334 biopsies. J Am Geriatr Soc. 1990;38:669-74.
99. Jennette JC, Falk RJ. Diagnosis and management of glomerular diseases. Med Clin North Am. 1997;81:653-77.
100. Gong WK, Tan TH, Murugasu B, et al. 18 years experience in pediatric acute dialysis: analysis of predictors of outcome. Pediatr Nephrol. 2001;16: 212-15.
101. Anochie IC, Eke FU. Pediatric acute peritoneal dialysis in southern Nigeria. Postgrad Med J. 2006;82: 228-30.
102. Phadke KD, Dinaker C. The challenges of treating children with renal failure in a developing country. Perit Dial Int. 2001;21:S326-S29.
103. Wong SN, Geary DF. Comparison of temporary and permanent catheters for acute peritoneal dialysis. Arch Dis Child. 1988;63:827-31.
104. Chadha V, Warady BA, Blowey DL, et al. Tenckhoff catheters prove superior to cook catheters in pediatric acute peritoneal dialysis. Am J Kidney Dis. 2000;35:1111-6.
105. Auron A, Warady BA, Simon S, et al. Use of the multipurpose drainage catheter for the provision of acute peritoneal dialysis in infants and children. Am J Kidney Dis. 2007;49:650-5.
106. Lamiere N. Principles of peritoneal dialysis and its application in acute renal failure, vol. 1357. In: Ronco C, Bellomo R, editors. Critical care nephrology. Dordrecht: Kluwer Academic Publishers; 1998.
107. Rubin J, Adair C, Barnes T, et al. Dialysate flow rate and peritoneal clearance. Am J Kidney Dis. 1984; 4:260-67.
108. Mehta RL, Letteri JM, National Kidney Foundation Council on Dialysis. Current status of renal replacement therapy for acute renal failure. Am J Nephrol. 1999;19:377-82.
109. Leblanc M, Tapoyai M, Paganini EP. What dialysis dose should be provided in acute renal failure? Adv Ren Replace Ther. 1995;2:255-64.
110. Schiff HMD, Lang MS. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med. 2002;348:305-10.
111. Ronco C, Bellomo R, Honel P. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomized trial. Lancet. 2002;356:26-30.
112. Chionh CY, Soni S, Cruz DN, et al. Peritoneal dialysis for acute kidney injury: techniques and dose. Contrib Nephrol. 2009;163:278-84.
113. Gabriel DP, do Nascimento GVR, Caramori JT, et al. High volume peritoneal dialysis for acute renal failure. Perit Dial Int. 2007;27:277-82.
114. Evanson JA, Ikizler TA, Wingard R, et al. Measurement of the delivery of dialysis in acute renal failure. Kidney Int. 1999;55:1501-8.
115. Himmelfarb J, Evanson J, Hakim RM, et al. Urea volume of distribution exceeds total body water in patients with acute renal failure. Kidney Int. 2002;61: 317-23.
116. Chitalia VC, Almeida AF, Rai H, et al. Is peritoneal dialysis adequate for hypercatabolic acute renal failure in developing countries? Kidney Int. 2002;61: 747-57.
117. Flynn JT, Kershaw DB, Smoyer WE, et al. Peritoneal dialysis for management of pediatric acute renal failure. Perit Dial Int. 2001;21:390-94.
118. Ronco C, Amerling R. Continuous flow peritoneal dialysis: current state-of-the-art and obstacles to further development. Contrib Nephrol. 2006;150: 310-20.
119. Raj DS, Self M, Work J. Hybrid dialysis: recirculation peritoneal dialysis revisited. Am J Kidney Dis. 2000;36:56-67.
120. Mineshima M, Suzuki S, Sato Y, et al. Solute removal characteristics of continuous recirculation peritoneal dialysis in experimental and clinical studies. ASAIO J. 2000;46:95-8.
121. Cruz C, Melendez A, Gotch FA, et al. Single-pass continuous flow peritoneal dialysis using two catheters. Semin Dial. 2001;14:391-4.
122. Frieda P, Issad B. Continuous flow peritoneal dialysis: assessment of fluid and solute removal in a high- flow model of “fresh dialysate single pass”. Perit Dial Int. 2003;23:348-55.
123. Amerling R, Glezerman I, Savransky E, et al. Continuous flow peritoneal dialysis: current perspectives. Contrib Nephrol. 2003;140:294-304.
124. Rajpoot DK, Gargus JJ. Acute hemodialysis for hyperammonemia in small neonates. Pediatr Nephrol. 2004;19:390-5.
125. Meyer RJ, Flynn JT, Brophy PD, et al. Hemodialysis followed by continuous hemofiltration for treatment of lithium intoxication in children. Am J Kidney Dis. 2001;37:1044-7.
126. McBryde KD, Kershaw DB, Bunchman TE, et al. Renal replacement therapy in the treatment of confirmed or suspected inborn errors of metabolism. J Pediatr. 2006;148:770-8.
127. Rabindranath K, Adams J, Macleod AM, et al. Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev. 2007;(3):CD003773.
128. Bagshaw SM, Berthiaume LR, Delaney A, et al. Continuous versus intermittent renal replacement therapy for critically ill patients with acute kidney injury: a meta-analysis. Crit Care Med. 2008;36: 610-7.
129. Antoun TA, Palevsky PM. Selection of modality of renal replacement therapy. Semin Dial. 2009;22: 108-13.
130. Strazdins V, Watson AR, Harvey B. Renal replacement therapy for acute renal failure in children. Pediatr Nephrol. 2004;19:199-207.
131. Schulman G, Fogo A, Gung A, et al. Complement activation retards resolution of acute ischemic renal failure in the rat. Kidney Int. 1991;40:1069-74.
132. Himmelfarb J, Zaoui P, Hakim RM. Modulation of granulocyte LAM-1 and MAC-1 during dialysis - a prospective, randomized controlled trial. Kidney Int. 1992;41:388-95.
133. Lamba NM, Gaylor JD, Courtney JM, et al. Complement activation by cellulose: investigation of the effects of time, area, flow rate, shear rate and temperature on C3a generation in vitro, using a parallel plate flow cell. J Mater Sci Mater Med. 1998;9: 409-14.
134. Varela MP, Kimmel PL, Phillips TM, et al. Biocompatibility of hemodialysis membranes: interrelations between plasma complement and cytokine levels. Blood Purif. 2001;19:370-9.
135. Himmelfarb J, Rubin NT, Chandran P, et al. A multicenter comparison of dialysis membranes in the treatment of acute renal failure requiring dialysis. J Am Soc Nephrol. 1998;9:257-66.
136. Jaber BL, Lau J, Schmid CH, et al. Effect of biocompatibility of hemodialysis membranes on mortality in acute renal failure: a meta-analysis. Clin Nephrol. 2002;57:274-82.
137. Subramainian S, Venkataraman R, Kellum J. Influence of dialysis membranes on outcomes in acute renal failure: a meta-analysis. Kidney Int. 2002;62:1819-23.
138. Alonso A, Lau J, Jaber BL. Biocompatible hemodialysis membranes for acute renal failure (Review). Cochrane Database Syst Rev. 2008;(1):CD005283.
139. Pannu N, Klarenbach S, Wiebe N, et al. Renal replacement therapy in patients with acute renal failure: a systematic review. JAMA. 2008;299:793-805.
140. Uchino S, Bellomo R, Morimatsu H, et al. Cytokine dialysis: an ex-vivo study. ASAIO J. 2002;48: 650-3.
141. Haase M, Bellomo R, Baldwin I, et al. Hemodialysis membrane with a high molecular-weight cutoff and cytokine levels in sepsis complicated by acute renal failure: a phase 1 randomized trial. Am J Kidney Dis. 2007;50:296-304.
142. Haase M, Bellomo R, Baldwin I, et al. High cut-off point membranes in septic acute renal failure: a systematic review. Int J Artif Organs. 2007;30:1031-1041.
143. Rimmelé T, Assadi A, Cattenoz M, et al. Highvolume haemofiltration with a new haemofiltration membrane having enhanced adsorption properties in septic pigs. Nephrol Dial Transplant. 2009;24: 421-27.
144. Brophy PD, Mottes TA, Kudelka TL, et al. AN-69 membrane reactions are pH-dependent and preventable. Am J Kidney Dis. 2001;38:173-8.
145. Pasko DA, Mottes TA, Mueller BA. Pre-dialysis of blood prime continuous hemodialysis normalizes pH and electrolytes. Pediatr Nephrol. 2003;18: 1177-83.
146. Hackbarth RM, Eding D, Gianoli Smith C, et al. Zero balance ultrafiltration (Z-BUF) in blood-primed CRRT circuits achieves electrolyte and acid-base homeostasis prior to patient connection. Pediatr Nephrol. 2005;20:1328-33.
147. Goldstein SL. Overview of pediatric renal replacement therapy in acute renal failure. Artif Organs. 2003;27:781-5.
148. Lai KN, Wang AY, Ho K, et al. Use of low-dose low molecular weight heparin in hemodialysis. Am J Kidney Dis. 1996;28:721-6.
149. Tolwani AJ, Wille KM. Anticoagulation for continuous renal replacement therapy. Semin Dial. 2009;22:141-5.
150. Schortgen F, Soubrier N, Delclaux C, et al. Hemodynamic tolerance of intermittent hemodialysis in critically ill patients: usefulnessof practice guidelines. Am J Respir Crit Care Med. 2000;162: 197-202.
151. Dheu C, Terzic J, Menouer S, et al. Importance of the curve shape for interpretation of blood volume monitor changes during haemodiafiltration. Pediatr Nephrol. 2009;24:1419-23.
152. Patel N, Dalal P, Panesar M. Dialysis disequilibrium syndrome: a narrative review. Semin Dial. 2008;21:493-98.
153. Ramos P, Marshall MR, Golper TA. Acute hemodialysis prescription. In: Berns SJ, Palevsky PM, Post TW, editors. UpToDate v17.3. www.uptodate.com. Accessed 30 Sep 2009.
154. Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med. 2002;346:305-10.
155. The VA/NIH Acute Renal Failure Trial Network. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008;359: 7-20.
156. Kudoh Y, Imura O. Slow continuous hemodialysis - new therapy for acute renal failure in critically ill patients - part 1. Theoretical consideration and new technique. Jpn Circ J. 1988;52:1171-82.
157. Kudoh Y, Shiiki M, Sasa Y, et al. Slow continuous hemodialysis - new therapy for acute renal failure in critically ill patients - part 2. Animal experiments and clinical implication. Jpn Circ J. 1988;52: 1183-90.
158. Tam PY, Huraib S, Mahan B, et al. Slow continuous hemodialysis for the management of complicated acute renal failure in an intensive care unit. Clin Nephrol. 1988;30:79-85.
159. Cruz D, Bobek I, Lentini P, et al. Machines for continuous renal replacement therapy. Semin Dial. 2009;22:123-32.
160. Fliser D, Kielstein JT. Technology insight: treatment of renal failure in the intensive care unit with extended dialysis. Nat Clin Pract Nephrol. 2006;2: 32-9.
161. Abi Antoun T, Palevsky PM. Selection of modality of renal replacement therapy. Semin Dial. 2009; 22:108-13.
162. Marshall M, Tianmin M, Galler D, et al. Sustained low-efficiency daily diafiltration (SLEDD-f) for critically ill patients requiring renal replacement therapy: towards an adequate therapy. Nephrol Dial Transplant. 2004;19:877-84.
163. Vaslaki L, Karatson A, Voros P, et al. Can sterile and pyrogen-free on-line substitution fluid be routinely delivered? A multicentric study on the microbiological safety of on-line haemodiafiltration. Nephrol Dial Transplant. 2000;15(Suppl 1):74-8.
164. Weber C, Groetsch W, Schlotter S, et al. Novel online infusate-assisted dialysis system performs microbiologically safely. Artif Organs. 2000;24: 323-8.
165. Kumar V, Craig M, Depner T, et al. Extended daily dialysis: a new approach to renal replacement therapy for acute renal failure in the intensive care unit. Am J Kidney Dis. 2000;36:294-300.
166. Morath C, Miftari N, Dikow R, et al. Sodium citrate anticoagulation during sustained low efficiency dialysis (SLED) in patients with acute renal failure and severely impaired liver function. Nephrol Dial Transplant. 2008;23:421-2.
167. Marshall MR, Golper TA. Sustained low efficiency or extended daily dialysis. In: Berns SJ, Palevsky PM, Post TW, editors. UpToDate®v17.3. www.upto- date.com. Accessed 30 Sep 2009.
168. Kielstein J, Kretschmer U, Ernst T, et al. Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study. Am J Kidney Dis. 2004;43:342-9.
169. Henderson LW. The beginning of clinical hemofiltration: a personal account. ASAIO J. 2003;49: 513-7.
170. Henderson LW, Livoti LG, Ford CA, Kelly AB, Lysaght MJ. Clinical experience with intermittent hemodiafiltration. Trans ASAIO. 1973;19:119-23.
171. Henderson LW. The birth of hemodiafiltration. Contrib Nephrol. 2007;158:1-8.
172. Kramer P, Wigger W, Rieger J, Matthaei D, Scheler F. Arteriovenous haemofiltration: a new and simple method for treatment of over-hydrated patients resistant to diuretics. Klin Wochenschr. 1977;55:1121-2.
173. Zobel G, Ring E, Trop M, Stein JI. Arteriovenous diafiltration in children. Int J Pediatr Nephrol. 1986;7:203-6.
174. Leone MR, Jenkins RD, Golper TA, Alexander SR. Early experience with continuous arteriovenous hemofiltration in critically ill pediatric patients. Crit Care Med. 1986;14:1058-63.
175. Ronco C, Brendolan A, Bragantini L, La Greca G. Treatment of acute renal failure in newborns by continuous arteriovenous hemofiltration. Trans ASAIO J. 1985;41:634-8.
176. Lieberman KV. Continuous arteriovenous hemofiltration in children. Pediatr Nephrol. 1987;1: 330-8.
177. Lopez-Herce J, Dorao P, Delgado MA, Espinoza L, Ruza F, Martinez MC. Continuous arteriovenous hemofiltration in children. Intensive Care Med. 1989;15:224-7.
178. Waradt B, Bunchman T. Dialysis therapy for children with acute renal failure: survey results. Pediatr Nephrol. 2000;15:11-3.
179. Goldstein S, Currier H, Graf J, Cosio CC, Brewer ED, Sacheva R. Outcome in children receiving continuous veno-venous hemofiltration. Pediatrics. 2001;107:1309-12.
180. Bunchman TE, Maxvold NJ, Kershaw DB, Sedman AB, Custer JR. Continuous venvenous hemofiltration in infants and children. Am J Kidney Dis. 1995;25:17-25.
181. Hmiel SP, Martin RA, Landt M, Levy FH, Grange DK. Amino acid clearance during acute metabolic decompensation in maple syrup urine disease treated with continuous venovenous hemodialysis with filtration. Pediatr Crit Care Med. 2004;5:278-81.
182. Ricci Z, Ronco C, Picardo S. CRRT in series with extracorporeal membrane oxygenation in pediatric patients. Kidney Int. 2010;77:469-70.
183. Jenkins R, Harrison H, Chen B, Arnold D, Funk J. Accuracy of intravenous infusion pumps in continuous renal replacement therapies. Trans ASAIO J. 1992;38:808-11.
184. Bunchman TE, Gardner JJ, Kershaw DB, Maxvold NJ. Vascular access for hemodialysis or CVVH(D) in infants and children. Nephrol Dial Transplant. 1994;23:314-7.
185. Davenport A, Will EJ, Davison AM. Hyperlactemia and metabolic acidosis during hemofiltration using lactate-buffered fluids. Nephron. 1991;59:461-5.
186. Thomas AN, Guy JM, Kishen R, Garaughty IF, Bowles BJM, Vadgama P. Comparison of lactate and bicarbonate buffered hemofiltration fluids: use in critically ill patients. Nephrol Dial Transplant. 1997;12:1212-17.
187. Zimmerman D, Cotman P, Ting R, Karanicolas S, Tobe SW. Continuous veno-venous hemodialysis with a novel bicarbonate dialysis solution: prospective crossover comparison with lactate buffered solution. Nephrol Dial Transplant. 1999; 14: 2387-91.
188. Maxvold NJ, Flynn JT, Smoyer WE, et al. Prospective crossover comparison of bicarbonate vs lactate- based dialysate for pediatric CVVHD. Blood Purif. 1999;17:27-9.
189. Parshuram CS, Cox PN. Neonatal hyperkalemic- hypocalcemic cardiac arrest associated with initiation of blood-primed continuous venovenous hemofiltration. Pediatr Crit Care Med. 2002;3:67-9.
190. Hackbarth RM, Eding D, Smith CG, Koch A, Sanfilippo DJ, Bunchman TE. Zero-balance ultrafiltration (Z-BUF) in blood-primed CRRT circuits achieves electrolyte and acid-base homeostasis prior to patient connection. Pediatr Nephrol. 2005;20: 1328-33.
191. Brophy PD, Somers MJ, Baum MA, et al. Multicenter evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT). Nephrol Dial Transplant. 2005;20:1416-2.
192. Mehta RL, McDonald BR, Aguilar MM, Ward DM. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int. 1990;38:976-81.
193. Bunchman TE, Maxvold NJ, Barnett J, Hutchings A, Benfield MR. Pediatric hemofiltration: normocarb dialysate solution with citrate anticoagulation. Pediatr Nephrol. 2002;17:150-4.
194. Chadha V, Garg U, Warady B, Alon US. Citrate clearance in children receiving continuous veno- venous renal replacement therapy. Pediatr Nephrol. 2002;17:819-24.
195. Meier-Kreische HU, Gitomer J, Finkel K, DuBose T. Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med. 2001;29:748-52.
196. Maxvold NJ, Smoyer WE, Custer JR, Bunchman TE. Amino acid loss and nitrogen balance in critically ill children with acute renal failure: a prospective comparison between classic hemofiltration and hemfiltration with dialysis. Crit Care Med. 2000;28:1161-5.
197. Mokrzycki MH, Kaplan AA. Protein losses in continuous renal replacement therapies. J Am Soc Nephrol. 1996;7:2259-63.
198. Braun MC, Welch TR. Continuous venovenous dia- filtration in the treatment of acute hyperammonemia. Am J Nephrol. 1998;18:531-3.
199. Falk MC, Knight JF, Roy LP, et al. Continuous veno- venous hemofiltration in the acute treatment of inborn errors of metabolism. Pediatr Nephrol. 1994;8:330-3.
200. Yorgin PD, Eklund DK, al-Uzri A, Whitesell L, Theodorou AA. Concurrent centrifugation plasmapheresis and continuous venovenous hemodiafiltra- tio. Pediatr Nephrol. 2000;14:18-21.
201. Yorgin P, Ludlow M, Chua A, Alexander S. A technique for rapid exchange of continuous renal replacement therapy. Pediatr Nephrol. 2006;21: 743-6.
202. Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous hemofiltration on outcomes of acute renal failure: a prospective randomized trial. Lancet. 2000;356: 26-30.
203. DiCarlo JV, Alexander SR. Hemofiltration for cytokine-driven illnesses: the mediator delivery hypothesis. Int J Artif Organs. 2005;28:777-86.
204. Honore PM, Joannes-Boyau O, Boer W, Collin V. High-volume hemofiltration in sepsis and SIRS: current concepts and future prospects. Blood Purif. 2009;28:1-11.
205. Goldstein SL, Currier H, Graf JM, Cosio CC, Brewer ED, Sachdeva R. Outcome in children receiving continuous hemofiltration. Pediatrics. 2001; 107: 1309-12.
206. Symons JM, Brophy PD, Gregory MJ, et al. Continuous renal replacement therapy in children up to 10 kg. Am J Kidney Dis. 2003;41:984-9.
207. Flores FX, Brophy PD, Symons JM, et al. CRRT after stem cell transplantation: a report from the prospective pediatric CRRT registry. Pediatr Nephrol. 2008;23:625-30.
208. Sutherland SM, Zappitelli M, Alexander SR, et al. Fluid overload and mortality in children receiving continuous renal replacement therapy: a report of the prospective pediatric CRRT registry. Am J Kidney Dis. 2010;55:316-25.